Leukemia News

Insurance and neighborhood socioeconomic status were significant mediators of inequity in CV mortality among Black and white cancer survivors, according to a study published in the International Journal of Epidemiology.

In this video, Jakub Svoboda, MD, discusses the results of the phase 3 Alliance study, pertaining to chronic lymphocytic leukemia, presented at ASCO Annual Meeting.

In this video, Jakub Svoboda, MD, discusses updated data on the results of the MOLTO study into Richter syndrome presented at ASCO Annual Meeting.

In this video, Jakub Svoboda, MD, discusses updated data on the results of lisocabtagene maraleucel chimeric antigen receptor T-cell therapy on chronic lymphocytic leukemia, presented at ASCO Annual Meeting.

UC San Diego researcher Catriona Jamieson, MD, PhD, likes to think of it as a “literal cancer moonshot.”

The FDA approved quizartinib for use in combination with standard chemotherapy for treatment of patients with newly diagnosed acute myeloid leukemia with FLT3 internal tandem duplication mutations.

A man has remained in treatment-free HIV remission for nearly 2 years after receiving a stem-cell transplant to treat a rare and aggressive form of leukemia, researchers reported Wednesday.

In this edition, obesity linked to adverse outcomes among AYAs; pirtobrutinib produces high response rates; CDC study reveals overall increase in pediatric cancer incidence and more.

Falls in an inpatient cancer rehabilitation unit occurred less frequently than previous studies have estimated and usually caused patients no harm, according to data published in JCO Oncology Practice.

Adolescents and young adults with overweight or obesity had poorer clinical outcomes than their normal-weight counterparts after receiving a pediatric regimen for treatment of acute lymphoblastic leukemia, study results showed.